Summary: Single nucleotide polymorphisms (SNPs) in genes coding for proteins that maintain the cytosolic aryl hydrocarbon receptor (AHR) complex may affect individual susceptibility to dioxin-like compound (DLC)-induced toxicity. The cytosolic 90 kDa heat shock proteins (HSP90s) are ubiquitous chaperone proteins that bind to and stabilize numerous client proteins, including non-ligand-bound AHR. The objective of this study was to characterize SNPs in the human cytosolic HSP90 genes (HSP90AA1 and HSP90AB1). DNA sequencing of 101 human samples detected eight and seven unique SNPs at the HSP90AA1 and HSP90AB1 loci, respectively. For HSP90AA1, two non-synonymous (L71M and E554D) and one rare early termination (Q107X) SNP were observed. One SNP (E554D) was a rare novel polymorphism located in the middle substrate binding region. All SNPs detected in the HSP90AB1 gene were synonymous. With the exception of Q107X, in silico analyses predicted all HSP90 SNPs would have very low to medium risk of affecting the regulation of alternative splicing in gene transcription or protein function. Overall, a very limited presence of SNPs with predicted functional consequence in key domains of the human HSP90 proteins was observed in this study.
Introduction
The environmental contaminant 2,3,7,8-tetrachlorodibenzo-p-dioxin ¤TCDD¥ is one of several dioxin-like compounds ¤DLCs¥, which are a group of ligands with common structural motifs that bind to and activate the aryl hydrocarbon receptor ¤AHR¥. Ligand activation of AHR, a member of the basic helix-loop-helix/Per-Arnt-Sim domain ¤bHLH/ PAS¥ transcription factor family, promotes the translocation to the nucleus and formation of an AHR-AHR nuclear translocator ¤ARNT¥ heterodimer, which then binds dioxin response elements ¤DREs¥ in the promoters of several target genes, thereby initiating the transcription of these genes ¤e.g., CYP1A1¥. In the absence of ligands, however, AHR is a cytosolic protein that exists as one component of a larger protein complex. This unliganded multiprotein complex includes an immunophilin-like AHR interacting protein ¤AIP¥, the phosphoprotein p23, and a 90-kDa heat shock protein ¤HSP90¥ dimer. Both ARNT and the protein chaperone HSP90 interact with the bHLH/PAS domains within the AHR protein. 1¥ This mutually exclusive proteinprotein interaction with AHR prevents the formation of the AHR-ARNT heterodimer in the absence of an AHR ligand. In addition to repressing AHR-ARNT heterodimerization and transcriptional activity, HSP90 is integral in regulating AHR cellular localization, 2¥ and also serves to maintain AHR in its correctly folded form for high-affinity ligand binding activity.
3, 4¥ The importance of HSP90ös role in the AHR pathway is underscored by the fact that HSP90 inhibitors are able to suppress AHR-mediated transcription activity.
5¥
HSP90 is a ubiquitous protein chaperone with an everexpanding array of known client proteins. 6¥ Most of the client proteins with which HSP90 interacts are involved in signal transduction, making HSP90 a critical factor in cell signaling pathways.
7,8¥ As such, HSP90 has become a target of pharmacotherapeutic development for neurodegenerative and autoimmune disease states. 9®11¥ The expression of HSP90 proteins also has been commonly observed to increase in several types of tumors, 12¥ and there has been much effort devoted towards the development of HSP90 inhibitors as chemotherapy agents. 13,14¥ In addition, these protein chaperones play an integral role in the growth and development of vertebrates. 15,16¥ There are two isoforms of cytosolic HSP90 proteins in humans: the inducible alpha isoform ¤HSP90AA1¥, and constitutive beta isoform ¤HSP90AB1¥. Their gene loci are on chromosome 14q32.33 ¤alpha¥ and chromosome 6p12 ¤beta¥, and both genes are comprised of 12 exons ¤Figs. 1 and 2¥. Additionally, the alpha isoform is comprised of two splice variants: long ¤854 amino acids¥ and short ¤732 amino acids¥ forms, the latter of which is lacking the first exon. The two isoforms have very similar amino acid sequence, with the beta isoform ¤724 amino acids¥ missing short sequences within exons 2 ¤amino acids 9®13¥ and 5 ¤amino acids 241® 243¥ relative to the short alpha isoform.
17,18¥ Each HSP90 isoform contains three highly conserved domains: an ATPbinding N-terminal domain, 19¥ a middle substrate binding domain ¤MSBD¥ that interacts with client proteins and harbors ATPase activity, 20¥ and a carboxyl terminal domain that is the primary interface site for HSP90 dimerization and that is responsible for binding tetratricopeptide repeat ¤TPR¥-containing chaperones. 21,22¥ The N-terminal and MSBD domains are connected by a linker region of charged amino acids, a region that contributes to structural flexibility and facilitates protein-protein interactions.
23,24¥
From a biomechanical perspective, the HSP90 dimer is hypothesized to work as an ATPase-coupled molecular clamp, where transient dimerization of the N-terminal domains is dependent upon the ATP hydrolysis cycle.
25¥
It has been hypothesized that genetic variability of AHR may confer susceptibility to the biological effects associated with DLC exposure. 26¥ Although there is little evidence to support the premise that SNPs in the coding regions AHR or AHR-related proteins ¤AIP, ARNT¥ increase DLC susceptibility, 27®30¥ in the current study we continue to examine the potential genetic variability in genes that code for critical components of the AHR signaling pathway. The objective of this investigation was to survey a subset of individual human DNA samples for SNPs at the HSP90AA1 and HSP90AB1 loci. DNA was obtained from immortalized human lymphocytes derived from six ethnic populations and sequenced in an effort to further identify single SNPs within the open reading frame of the HSP90AA1 and HSP90AB1 loci. The potential impact of the detected SNPs on HSP90 protein structure and function, as well as the regulation of splice variation, was predicted using an in silico approach. The identification and characterization of genetic variants in the human population is an important step in studying the potential variation in sensitivity to DLCs, particularly in the context of evaluating human health risk associated with exposure to DLCs. 1. An approximate representation of the human heat shock protein 90 kDa alpha isoform (HSP90AA1) locus based on information presented in previous literature (Chen et al., 2005) and the ENSEMBL database: http://uswest.ensembl.org/Homo_sapiens/Transcript/ Summary?db¦core;g¦ENSG00000080824;r¦14:102547073-102606086;t¦ENST00000334701
The genome sequence is shown at the bottom with the exons denoted as numbers, and grey and darkened boxes representing untranslated and translated sequences, respectively. Introns are depicted as intervening lines. The deduced cDNA or mRNA is shown at the top. SNPs identified in this study are indicated by black arrows (non-synonymous), grey arrows (synonymous), and a hatched arrow (stop codon generated). Table 1 ¤synthesized at Integrated DNA Technologies, 1 µl for each direction at primer concentrations of 10 pmol/µl¥. The PCR reaction mixtures, procedure, and purification method were the same as those reported previously. 28¥ Detection and sequencing of SNPs was conducted using Mutation Surveyor Software ¬ v. 3.10 ¤SoftGenetics ¬ , Pennsylvania, USA¥, and was confirmed by opposing strand sequencing. Results were compared with the human HSP90 alpha and beta SNPs documented in the National Center for Biotechnology Information SNP database ¤dbSNP¥: http://www.ncbi.nlm.nih.gov/SNP ¤ac-cessed on September 15, 2011¥. Those SNPs not listed in the dbSNP for these loci were characterized as novel. The SNP data for each sample were used to calculate study-specific SNP genomic and allelic frequencies.
It should be noted that for HSP90AA1, one sample ¤NA17112¥ produced an ambiguous result for SNP D821D ¤rs11547523¥. Mutation Surveyor called the alleles úT/T,û but there was a small úCû peak underneath the úTû peak. This peak was approximately half the size of a normal heterozygote SNP peak. PCR for this sample was re-run several times, but the result remained ambiguous. A new stock of the sample was ordered from Coriell, but this sample also produced a small úCû peak underneath a large úTû peak, although it was smaller than before. The small height of the peak led us to conclude that it was not a heterozygous SNP, so it was decided that this sample should be classified as a úT/Tû genotype.
Additionally, in silico analysis was conducted to evaluate the potential impact of the observed HSP90 alpha and beta SNPs¯both novel and known¯on splicing regulation and protein function. Because the available bioinformatics tools cover a diverse group of functions and predictive methodologies, 31¥ a combination of bioinformatics tools was used to analyze HSP90 alpha and beta genetic variants: Human Splicing Finder ¤HSF¥ and FastSNP. HSF ¤http://www. umd.be/HSF/¥ was used to predict the effects of variants on potential splice sites using default settings. 32¥ A SNP was considered to alter canonical splice sites, or activate cryptic splice sites, if the variation in consensus values between wildtype and mutant differed by hq100%q. FastSNP ¤http:// FASTSNP.ibms.sinica.edu.tw¥ is an integrated bioinformatics tool that was employed to make predictions about the impact of the SNPs on HSP90 alpha and beta protein function. This tool utilizes a decision tree principle that generates a specific risk score to characterize the predicted effect, where a risk score range of 0®5 is given, with 0 signifying no risk of an effect, and 5 corresponding to very high risk of an effect.
33¥

Results
PCR and sequencing analysis of the HSP90AA1 and HSP90AB1 loci in the 101 human DNA samples revealed eight and seven unique SNPs, respectively ¤Table 2¥. For HSP90AA1, two non-synonymous ¤L71M and E554D¥ and one early termination ¤Q107X¥ SNP were observed. The only novel SNP detected was E554D. In contrast, all SNPs detected in the HSP90AB1 gene were synonymous.
Results for HSP90AA1: Of the 101 samples evaluated for HSP90AA1 SNPs, eight had only one SNP, six had two SNPs, 41 had three SNPs, and two had four SNPs. Prior to this study, 82 HSP90AA1 exonic SNPs had been registered with the dbSNP, 75 of which were not detected in the DNA samples examined in the current study. The current analysis identified SNPs in exons 2, 7, 8, 9, and 12, with nonsynonymous SNPs located in the pre-N-terminal and MSBD domains, respectively ¤Fig. 1¥. The NCBI database indicates that SNPs have also been reported in the N-terminal and charged linker domains in the human population, though this was not corroborated in the current study. The eight SNPs identified here are discussed below in the context of their respective protein regions or domains.
Pre-N-terminal region ¤exons 1®2¥
The first two exons of the HSP90AA1 gene define an amino acid sequence of no specific function that precedes the N-terminal domain. Three SNPs were identified within this region¯all in exon 2¯for the current population: 556ThA ¤L71M¥, 627ThC ¤T94T¥, and 664ChT ¤Q107X¥ ¤Table 3¥. The first two SNPs were relatively common alleles in the general population and within each ethnicity, with total allelic frequencies of over 20% ¤L71M¥ and 30% ¤T94T¥. In contrast, the SNP predicted to result in a premature termination of the HSP90 alpha amino acid sequence was only detected in one allele ¤African American, heterozygous¥. The minor allelic frequencies ¤MAFs¥ for these three SNPs ¤21%, 33%, and 1%, respectively¥ correspond with what has been reported in the dbSNP to date ¤21%, 32%, and 1%, respectively¥. At the time of this study, there were eight additional SNPs ¤six non-synonymous¥ in the pre-N-terminal region of the HSP90 alpha protein that had been registered with the dbSNP that were not detected in the current study. However, these additional SNPs appear to be very rare as their associated allelic frequencies are below 1%. 
Middle substrate binding domain ¤exons 6®11¥
Four SNPs were identified in the MSBD of the HSP90AA1 gene: 1791ThC ¤N482N¥, 1995GhA ¤A550A¥, GhT ¤E554D¥, and 2097GhA ¤L584L¥. As shown in Table 4 , the most frequently detected of these SNPs was N482N, which was identified among all ethnic groups examined. The one novel SNP identified in this study was the nonsynonymous polymorphism E554D, which was identified on only one allele in one Mexican individual. Interestingly, this was the only HSP90AA1 SNP detected in this individualös genetic sample. The remaining two SNPs were synonymous and were observed at very low frequencies, being detected in one ¤L584L¥ or four ¤A550A¥ African American individuals. The MAFs for the three known SNPs ¤N482N © 33%, A550A © 2%, and L584L © 1%¥ were similar to those listed in the dbSNP ¤32%, 1%, and 2%, respectively¥. In addition to these three known SNPs, there have been nearly 30 other SNPs ¤of which 13 are non-synonymous¥ registered with the dbSNP for this domain of the HSP90AA1 gene that were not detected in the current study. However, these additional SNPs have reported allelic frequencies of less than 1%, making them very rare.
C-terminal domain ¤exons 11®12¥
The last HSP90AA1 SNP detected was observed in the C-terminal domain: 2808ThC ¤D821D¥ ¤Table 5¥. This was also a rare synonymous SNP, being detected in only three African Americans, one Japanese individual, and one Chinese individual. As had been observed with the other known SNPs, the MAF for D821D ¤2%¥ was very similar to that reported in the dbSNP ¤3%¥. None of the other 13 dbSNP-registered SNPs ¤four non-synonymous¥ in this region that were not detected in the current study had reported allelic frequencies greater than 1%.
Results for HSP90AB1:
The results indicated that there was much less variation at the HSP90AB1 locus than was observed for HSP90AA1. Of the 101 samples evaluated for HSP90AB1 SNPs, 53 had only one SNP, and three had two SNPs. There have been 78 exonic SNPs identified at the HSP90AB1 locus registered with the dbSNP, 71 of which were not detected in the DNA samples examined in the current study. The current analysis identified SNPs in exons 6, 7, 9, 10, and 12, all of which were synonymous and located either within the charged linker region, MSBD, or C-terminal region ¤Fig. 2¥. The seven SNPs identified here are discussed below in the context of their respective protein regions or domains.
Charged linker region ¤exon 6¥
One of the seven SNPs identified at the HSP90AB1 locus was detected in exon 6 ¤825GhA; K247K¥, most of which comprises the charged linker region of the HSP90 beta isoform. This SNP was a common polymorphism found across all ethnicities examined ¤Table 6¥. The MAF for this SNP ¤33%¥ corresponded with that reported in the dbSNP ¤31%¥. Neither of the other two dbSNP-registered SNPs ¤all non-synonymous¥ in this region not detected in the current study population had reported allelic frequencies greater than 1%. Middle substrate binding domain ¤exons 6®11¥ Five SNPs were identified in the MSBD of the HSP90AB1 gene: 1074GhA ¤R330R¥, 1083AhG ¤L333L¥, 1425ChT ¤N447N¥, 1614GhA ¤V510V¥, and 1737GhA ¤K551K¥. As shown in Table 7 , all of these synonymous SNPs were rare, none being associated with more than two individuals out of the current study population. The R330R, N447N, and K551K SNPs were found exclusively among African Americans, while the L333L polymorphism was only found in the Chinese population. V510V, on the other hand, was detected in both the African American and Hispanic populations. The MAFs for R330R, L333L, and N447N corresponded with those reported in the dbSNP ¤:1%¥, while the MAFs for V510V and K551K were reported to be slightly higher in the dbSNP ¤approximately 5%¥. In addition to these five known SNPs, there have been another 27 SNPs ¤of which 11 are non-synonymous¥ registered with the dbSNP for the MSBD of the HSP90AB1 gene that were not detected in the current study. However, these additional SNPs have reported allelic frequencies of less than 1%, making them very rare.
C-terminal region ¤exons 11®12¥
The last HSP90AB1 SNP detected was observed in the C-terminal domain: 2217ChT ¤L711L¥ ¤Table 8¥. This synonymous SNP was only detected in one Chinese individual. The MAF reported in the dbSNP for this known SNP ¤3%¥ is somewhat greater than was found in the current study ¤1%¥. With two exceptions, the other 16 dbSNPregistered SNPs ¤7 non-synonymous¥ in the C-terminal domain that were not detected in the current study had reported allelic frequencies greater than 1%. The excep- tions, G713G and R719H were still rare, though, both having allelic frequencies below 5% ¤4% and 2%, respectively¥.
In silico evaluation of the impact of detected SNPs on alternative splicing and protein function: Depending upon their location within a gene sequence, polymorphisms have the potential of affecting protein structure and function directly via amino acid substitutions ¤non-synonymous SNPs¥ and indirectly by affecting splice regulation ¤both synonymous and non-synonymous SNPs¥. The potential impact that the detected SNPs might have on protein function or elements that regulate alternative splicing was evaluated using the web-based FastSNP and HSF models, respectively. The FastSNP results show that only one of the 15 SNPs was predicted to have a high probability of impacting normal protein function ¤Table 9¥. This SNP, the nucleotide substitution for which results in a stop codon in the HSP90 alpha isoform polypeptide at amino acid 107, is expected to produce a truncated, non-functional HSP90 alpha protein product. Both of the non-synonymous SNPs, including the novel E554D SNP, involved conservative amino acid substitutions, and therefore were not predicted to impact protein structure or function. The non-synonymous SNPs, along with seven synonymous SNPs, were predicted to have a low to medium impact based on potential effects on the regulation of alternative splicing for the HSP90 genes. Most of these SNPs were detected in the HSP90AA1 gene. Results of the HSF modeling of potential splice site effects indicated that none of the 15 polymorphisms detected in the study population would be expected to significantly affect potential donor or acceptor splice sites compared to the wildtype sequence.
Discussion
A total of 15 exonic SNPs were identified at the HSP90AA1 and HSP90AB1 loci in 101 human DNA samples, including one novel non-synonymous polymorphism ¤E554D¥ in the alpha isoform. This novel SNP, located in the MSBD, was present at a very low frequency, being detected in only one allele in one individual. A few recent studies have shown that specific point mutations within the MSBD affected HSP90 protein dimerization capability. 18,34,35¥ However, the position of the novel SNP is located in the MSBD sequence upstream of the region putatively involved in HSP90 protein dimerization. Furthermore, the amino acid substitution resulting from the novel HSP90 alpha SNP ¤glutamic acid to aspartic acid¥ in the current study represents a conservative residue change, and is not predicted to affect HSP90 alpha protein structure ¤Table 9¥. The only other non-synonymous SNP detected in the population was L71M, a relatively common amino acid substitution detected in the pre-N-terminal region of HSP90 alpha that was also predicted to have no effect on protein structure.
Of the 12 synonymous SNPs identified in the current study, only one ¤HSP90 alpha: D821D¥ is located near an intron-exon splice junction ¤3rd codon from the beginning of exon 12¥, and therefore would be the only SNP expected to directly affect these important transcription sequences. In silico analysis indicated that this ChT nucleotide substitution would abolish sequences associated with exonic splicing enhancer proteins, but predicted that this would have a minimal risk of affecting the C-terminal protein domain. These results indicated that these silent SNPs are unlikely to affect alternative splicing within the HSP90 transcripts, although in vitro mRNA analysis is required to validate these predictions. Overall, the in silico analyses predicted that only the termination SNP ¤Q107X¥ had a high probability risk of impacting HSP90 protein function, a heterozygous polymorphism that was only found in one individual. Based on the information in the dbSNP for this polymorphism, there is only one other individual that has been reported to carry this allele, and there is no evidence that this allele is expressed in a homozygous fashion. Previous evidence suggests that only one functional allele is necessary for normal HSP90 alpha activity, although it has been speculated that only carrying a single functional allele could make an individual susceptible in circumstances of stress ¤i.e., disease¥ or accumulated defective proteins ¤i.e., advanced age¥.
35,36¥
To date there have been only two published investigations that have examined the presence of cytosolic HSP90 SNPs in the human population. Passarino et al. ¤2003¥ sampled 73 Caucasian Italians and detected three coding SNPs in the , and R612R are equivalent to N482N, Q610H, and R734R in the long alpha isoform.¥ The two most common of these SNPs ¤N360N and K247K¥ were detected in the current study, and all three of the synonymous SNPs were observed at frequencies similar to that reported in the NCBI dbSNP. However, neither of the non-synonymous SNPs was observed in the current population or was present in the dbSNP at the time this manuscript was submitted for publication. The authors reported that both non-synonymous SNPs were rare, being observed in only one heterozygous individual in each case. The discovery of the two non-synonymous SNPs was followed by in vitro investigations into their functional implications. While the results indicated that the V656M substitution in the beta isoform did not appear to affect HSP90 function, the HSP90 alpha SNP Q488H had a distinct effect on function, 35¥ presumably by disrupting the dimeric interaction. 34¥ The impact of this SNP on human response to environmental stimuli and health remains to be seen, however, since it has only been detected in one heterozygous individual to date.
The other human study of cytosolic HSP90 SNPs was a clinical investigation conducted in a small number of infertile patients with varicocele. 37¥ The authors focused on the HSP90 beta isoform, and only detected two synonymous SNPs ¤N150N and K552K¥ in one patient each. These SNPs also appear to be novel in that they have not been reported by anyone else to date, and there has been no effort published that has examined their potential impact on HSP90AB1 gene splicing.
In conclusion, this study identified 15 SNPs at the HSP90AA1 and HSP90AB1 loci, including two non-synonymous SNPs and one stop codon-generating SNP. Only the last SNP was expected to have a significant impact on protein structure and function, though there were several SNPs ¤including the novel E554D¥ that were predicted to have a low to moderate probability of impacting gene splicing regulation. In contrast to the HSP90 SNPs reported in the NCBI dbSNP, there were no non-synonymous SNPs detected in either the N-terminal or C-terminal domains of either HSP90 isoform gene in the current study population. At this point the evidence in the peer-reviewed literature indicates that SNPs that could potentially disrupt human cytosolic HSP90 dimerization and function are very rare. Indeed, when such SNPs are detected they have been accompanied by a wildtype HSP90 allele. This may not be surprising given that HSP90 genes have been highly conserved across species. 17¥ Based on these results alone it does not seem likely that the HSP90 SNPs would affect AHR-based signaling. In the context of previous studies that examined exonic polymorphisms in AHR, AIP, and ARNT, 27®30,38¥ there continues to be a paucity of evidence supporting the hypothesis that natural genetic variation in the human population at gene loci integral to the AHR signaling pathway defines a DLC susceptible subpopulation. Even so, the in silico results only provide a limited prediction of functional effect, and therefore it would be beneficial to validate the in silico results for L71M and E554D using functional assays.
